William Q. Sargent Jr.Vice-President, Investor Relations and Corporate Communications+1-484-321-5900 email@example.comSOURCE Auxilium Pharmaceuticals, Inc.
U.S. Food And Drug Administration Accepts XIAFLEX® Supplemental Biologics License Application Filing For The Treatment Of Peyronie's Disease
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts